-
1
-
-
33746101500
-
Epidemiology and natural history of genital human papillomavirus infection
-
Weaver BA. Epidemiology and natural history of genital human papillomavirus infection. J Am Osteopath Assoc 2006;106(3 Suppl 1): S2-S8.
-
(2006)
J Am Osteopath Assoc
, vol.106
, Issue.3 SUPPL. 1
-
-
Weaver, B.A.1
-
2
-
-
79956147544
-
Age-specific prevalence of human papillomavirus infection in males: A global review
-
Smith JS, Gilbert PA, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health 2011;48:540-52.
-
(2011)
J Adolesc Health
, vol.48
, pp. 540-552
-
-
Smith, J.S.1
Gilbert, P.A.2
Melendy, A.3
Rana, R.K.4
Pimenta, J.M.5
-
3
-
-
33749631190
-
Prevalence of HPV infection among men: A systematic review of the literature
-
Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006;194:1044-57.
-
(2006)
J Infect Dis
, vol.194
, pp. 1044-1057
-
-
Dunne, E.F.1
Nielson, C.M.2
Stone, K.M.3
Markowitz, L.E.4
Giuliano, A.R.5
-
4
-
-
79952487617
-
Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study
-
Giuliano AR, Lee JH, Fulp W, Villa LL, Lazcano E, Papenfuss MR, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011;377:932-40.
-
(2011)
Lancet
, vol.377
, pp. 932-940
-
-
Giuliano, A.R.1
Lee, J.H.2
Fulp, W.3
Villa, L.L.4
Lazcano, E.5
Papenfuss, M.R.6
-
5
-
-
50849126768
-
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia
-
Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008;26 Suppl 10:K1-16.
-
(2008)
Vaccine
, vol.26
, Issue.SUPPL. 10
-
-
Bosch, F.X.1
Burchell, A.N.2
Schiffman, M.3
Giuliano, A.R.4
De Sanjose, S.5
Bruni, L.6
-
6
-
-
78649445000
-
Factors affecting transmission of mucosal human papillomavirus
-
Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis 2010;10:862-74.
-
(2010)
Lancet Infect Dis
, vol.10
, pp. 862-874
-
-
Veldhuijzen, N.J.1
Snijders, P.J.2
Reiss, P.3
Meijer, C.J.4
Van De Wijgert, J.H.5
-
7
-
-
69249101307
-
Epidemiology of mucosal human papillomavirus infection and associated diseases
-
Trottier H, Burchell AN. Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics 2009;12:291-307.
-
(2009)
Public Health Genomics
, vol.12
, pp. 291-307
-
-
Trottier, H.1
Burchell, A.N.2
-
8
-
-
84906414957
-
Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: A prospective study
-
Van Doornum GJ, Prins M, Juffermans LH, Hooykaas C, van den Hoek JA, Coutinho RA, et al. Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourin Med 1994; 70:240-6.
-
(1994)
Genitourin Med
, vol.70
, pp. 240-246
-
-
Van Doornum, G.J.1
Prins, M.2
Juffermans, L.H.3
Hooykaas, C.4
Van Den Hoek, J.A.5
Coutinho, R.A.6
-
9
-
-
51749089550
-
Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men
-
Giuliano AR, Lu B, Nielson CM, Flores R, Papenfuss MR, Lee JH, et al. Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J Infect Dis 2008;198: 827-35.
-
(2008)
J Infect Dis
, vol.198
, pp. 827-835
-
-
Giuliano, A.R.1
Lu, B.2
Nielson, C.M.3
Flores, R.4
Papenfuss, M.R.5
Lee, J.H.6
-
10
-
-
20444373371
-
Acquisition and persistence of human papillomavirus infection in younger men: A prospective follow-up study among Danish soldiers
-
Kjaer SK, Munk C, Winther JF, Jorgensen HO, Meijer CJ, van den Brule AJ. Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev 2005;14:1528-33.
-
(2005)
Cancer Epidemiol Biomarkers Prev
, vol.14
, pp. 1528-1533
-
-
Kjaer, S.K.1
Munk, C.2
Winther, J.F.3
Jorgensen, H.O.4
Meijer, C.J.5
Van Den Brule, A.J.6
-
11
-
-
22244491950
-
Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men
-
Lajous M, Mueller N, Cruz-Valdez A, Aguilar LV, Franceschi S, Hernandez- Avila M, et al. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev 2005;14:1710-6.
-
(2005)
Cancer Epidemiol Biomarkers Prev
, vol.14
, pp. 1710-1716
-
-
Lajous, M.1
Mueller, N.2
Cruz-Valdez, A.3
Aguilar, L.V.4
Franceschi, S.5
Hernandez- Avila, M.6
-
12
-
-
56149122292
-
HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy
-
De Vuyst H, Lillo F, Broutet N, Smith JS. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev 2008;17:545-54.
-
(2008)
Eur J Cancer Prev
, vol.17
, pp. 545-554
-
-
De Vuyst, H.1
Lillo, F.2
Broutet, N.3
Smith, J.S.4
-
13
-
-
84861555009
-
Impact of human immunodeficiency virus on the natural history of human papillomavirus genital infection in South African men and women
-
Mbulawa ZZ, Marais DJ, Johnson LF, Coetzee D, Williamson AL. Impact of human immunodeficiency virus on the natural history of human papillomavirus genital infection in South African men and women. J Infect Dis 2012;206:15-27.
-
(2012)
J Infect Dis
, vol.206
, pp. 15-27
-
-
Mbulawa, Z.Z.1
Marais, D.J.2
Johnson, L.F.3
Coetzee, D.4
Williamson, A.L.5
-
14
-
-
77957997448
-
HPV: Immune response to infection and vaccination
-
Stanley M. HPV: immune response to infection and vaccination. Infect Agent Cancer 2010;5:19.
-
(2010)
Infect Agent Cancer
, vol.5
, pp. 19
-
-
Stanley, M.1
-
15
-
-
0034085544
-
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection
-
Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, et al. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000; 181:1911-9.
-
(2000)
J Infect Dis
, vol.181
, pp. 1911-1919
-
-
Carter, J.J.1
Koutsky, L.A.2
Hughes, J.P.3
Lee, S.K.4
Kuypers, J.5
Kiviat, N.6
-
16
-
-
70349304201
-
Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004
-
Markowitz LE, Sternberg M, Dunne EF, McQuillan G, Unger ER. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis 2009;200:1059-67.
-
(2009)
J Infect Dis
, vol.200
, pp. 1059-1067
-
-
Markowitz, L.E.1
Sternberg, M.2
Dunne, E.F.3
McQuillan, G.4
Unger, E.R.5
-
17
-
-
84862969651
-
Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: A global review
-
Tiggelaar SM, Lin MJ, Viscidi RP, Ji J, Smith JS. Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review. J Adolesc Health 2012;50:110-31.
-
(2012)
J Adolesc Health
, vol.50
, pp. 110-131
-
-
Tiggelaar, S.M.1
Lin, M.J.2
Viscidi, R.P.3
Ji, J.4
Smith, J.S.5
-
18
-
-
79958728655
-
Serum antibody response following genital {alpha}9 human papillomavirus infection in young men
-
Edelstein ZR, Carter JJ, Garg R, Winer RL, Feng Q, Galloway DA, et al. Serum antibody response following genital {alpha}9 human papillomavirus infection in young men. J Infect Dis 2011;204:209-16.
-
(2011)
J Infect Dis
, vol.204
, pp. 209-216
-
-
Edelstein, Z.R.1
Carter, J.J.2
Garg, R.3
Winer, R.L.4
Feng, Q.5
Galloway, D.A.6
-
19
-
-
1642527944
-
Natural history of human papillomavirus type 16 virus-like particle antibodies in young women
-
Ho GY, Studentsov YY, Bierman R, Burk RD. Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol Biomarkers Prev 2004;13:110-6.
-
(2004)
Cancer Epidemiol Biomarkers Prev
, vol.13
, pp. 110-116
-
-
Ho, G.Y.1
Studentsov, Y.Y.2
Bierman, R.3
Burk, R.D.4
-
20
-
-
0031008091
-
Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia
-
de Gruijl TD, Bontkes HJ, Walboomers JM, Schiller JT, Stukart MJ, Groot BS, et al. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. J Natl Cancer Inst 1997;89:630-8.
-
(1997)
J Natl Cancer Inst
, vol.89
, pp. 630-638
-
-
De Gruijl, T.D.1
Bontkes, H.J.2
Walboomers, J.M.3
Schiller, J.T.4
Stukart, M.J.5
Groot, B.S.6
-
21
-
-
78650748371
-
Persistence of human papillomavirus infection: Keys to malignant progression
-
Bodily J, Laimins LA. Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol 2011;19:33-9.
-
(2011)
Trends Microbiol
, vol.19
, pp. 33-39
-
-
Bodily, J.1
Laimins, L.A.2
-
22
-
-
50849099522
-
Epidemiology ofhuman papillomavirus infection in men, cancers other than cervical and benign conditions
-
Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, et al. Epidemiology ofhuman papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 2008;26 Suppl 10:K17-28.
-
(2008)
Vaccine
, vol.26 SUPPL. 10
-
-
Giuliano, A.R.1
Tortolero-Luna, G.2
Ferrer, E.3
Burchell, A.N.4
De Sanjose, S.5
Kjaer, S.K.6
-
23
-
-
64849105830
-
A review of human carcinogens-part B: Biological agents
-
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens-part B: biological agents. Lancet Oncol 2009;10:321-2.
-
(2009)
Lancet Oncol
, vol.10
, pp. 321-322
-
-
Bouvard, V.1
Baan, R.2
Straif, K.3
Grosse, Y.4
Secretan, B.5
El Ghissassi, F.6
-
24
-
-
84055200240
-
The known unknowns of HPV natural history
-
Gravitt PE. The known unknowns of HPV natural history. J Clin Invest 2011;121:4593-9.
-
(2011)
J Clin Invest
, vol.121
, pp. 4593-4599
-
-
Gravitt, P.E.1
-
25
-
-
78149327887
-
Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections
-
Safaeian M, Porras C, Schiffman M, Rodriguez AC, Wacholder S, Gonzalez P, et al. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections. J Natl Cancer Inst 2010;102:1653-62.
-
(2010)
J Natl Cancer Inst
, vol.102
, pp. 1653-1662
-
-
Safaeian, M.1
Porras, C.2
Schiffman, M.3
Rodriguez, A.C.4
Wacholder, S.5
Gonzalez, P.6
-
26
-
-
71449126003
-
Persistent antibodies to HPV viruslike particles following natural infection are protective against subsequent cervicovaginal infection with related and unrelated HPV
-
Malik ZA, Hailpern SM, Burk RD. Persistent antibodies to HPV viruslike particles following natural infection are protective against subsequent cervicovaginal infection with related and unrelated HPV. Viral Immunol 2009;22:445-9.
-
(2009)
Viral Immunol
, vol.22
, pp. 445-449
-
-
Malik, Z.A.1
Hailpern, S.M.2
Burk, R.D.3
-
27
-
-
0037105643
-
Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles
-
Ho GY, Studentsov Y, Hall CB, Bierman R, Beardsley L, Lempa M, et al. Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles. J Infect Dis 2002;186:737-42.
-
(2002)
J Infect Dis
, vol.186
, pp. 737-742
-
-
Ho, G.Y.1
Studentsov, Y.2
Hall, C.B.3
Bierman, R.4
Beardsley, L.5
Lempa, M.6
-
28
-
-
84863072028
-
Prevalent serum antibody is not a marker of immune protection against acquisition of oncogenic HPV16 in men
-
Lu B, Viscidi RP, Wu Y, Lee JH, Nyitray AG, Villa LL, et al. Prevalent serum antibody is not a marker of immune protection against acquisition of oncogenic HPV16 in men. Cancer Res 2012;72:676-85.
-
(2012)
Cancer Res
, vol.72
, pp. 676-685
-
-
Lu, B.1
Viscidi, R.P.2
Wu, Y.3
Lee, J.H.4
Nyitray, A.G.5
Villa, L.L.6
-
29
-
-
78449268068
-
Human papillomavirus infection and reinfection in adult women: The role of sexual activity and natural immunity
-
Trottier H, Ferreira S, Thomann P, Costa MC, Sobrinho JS, Prado JC, et al. Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. Cancer Res 2010;70: 8569-77.
-
(2010)
Cancer Res
, vol.70
, pp. 8569-8577
-
-
Trottier, H.1
Ferreira, S.2
Thomann, P.3
Costa, M.C.4
Sobrinho, J.S.5
Prado, J.C.6
-
30
-
-
8444249386
-
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial
-
Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004;364:1757-65.
-
(2004)
Lancet
, vol.364
, pp. 1757-1765
-
-
Harper, D.M.1
Franco, E.L.2
Wheeler, C.3
Ferris, D.G.4
Jenkins, D.5
Schuind, A.6
-
31
-
-
33746839247
-
Immunologic Responses Following Administration of A Vaccine Targeting Human Papillomavirus Types 6 11, 16, and 18
-
Villa LL, Ault KA, Giuliano AR, Costa RL, Petta CA, Andrade RP, et al. Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16, and 18. Vaccine 2006; 24:5571-83.
-
(2006)
Vaccine
, vol.24
, pp. 5571-5583
-
-
Villa, L.L.1
Ault, K.A.2
Giuliano, A.R.3
Costa, R.L.4
Petta, C.A.5
Andrade, R.P.6
-
32
-
-
79951515760
-
Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: A 25-year prospective cohort study
-
Jansen IA, Geskus RB, Davidovich U, Jurriaans S, Coutinho RA, Prins M, et al. Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study. AIDS 2011;25:493-501.
-
(2011)
AIDS
, vol.25
, pp. 493-501
-
-
Jansen, I.A.1
Geskus, R.B.2
Davidovich, U.3
Jurriaans, S.4
Coutinho, R.A.5
Prins, M.6
-
33
-
-
68249086337
-
Opting out increases HIV testing in a large sexually transmitted infections outpatient clinic
-
Heijman RL, Stolte IG, Thiesbrummel HF, van Leent E, Coutinho RA, Fennema JS, et al. Opting out increases HIV testing in a large sexually transmitted infections outpatient clinic. Sex Transm Infect 2009;85: 249-55.
-
(2009)
Sex Transm Infect
, vol.85
, pp. 249-255
-
-
Heijman, R.L.1
Stolte, I.G.2
Thiesbrummel, H.F.3
Van Leent, E.4
Coutinho, R.A.5
Fennema, J.S.6
-
34
-
-
84867475081
-
Seroprevalence of seven high-risk HPV types in the Netherlands
-
Scherpenisse M, Mollers M, Schepp RM, Boot HJ, de Melker HE, Meijer CJ, et al. Seroprevalence of seven high-risk HPV types in The Netherlands. Vaccine 2012;30:6686-93.
-
(2012)
Vaccine
, vol.30
, pp. 6686-6693
-
-
Scherpenisse, M.1
Mollers, M.2
Schepp, R.M.3
Boot, H.J.4
De Melker, H.E.5
Meijer, C.J.6
-
35
-
-
27644558808
-
Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6 11, 16, and 18
-
Dias D, Van Doren J, Schlottmann S, Kelly S, Puchalski D, Ruiz W, et al. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diagn Lab Immunol 2005;12:959-69.
-
(2005)
Clin Diagn Lab Immunol
, vol.12
, pp. 959-969
-
-
Dias, D.1
Van Doren, J.2
Schlottmann, S.3
Kelly, S.4
Puchalski, D.5
Ruiz, W.6
-
36
-
-
0037246949
-
Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-like Particles for Human Papillomavirus Types 6 11, 16, and 18 by A Multiplexed Luminex Assay
-
Opalka D, Lachman CE, MacMullen SA, Jansen KU, Smith JF, Chirmule N, et al. Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay. Clin Diagn Lab Immunol 2003;10:108-15.
-
(2003)
Clin Diagn Lab Immunol
, vol.10
, pp. 108-115
-
-
Opalka, D.1
Lachman, C.E.2
Macmullen, S.A.3
Jansen, K.U.4
Smith, J.F.5
Chirmule, N.6
-
37
-
-
77951992662
-
Multiplexed serologic assay for nine anogenital human papillomavirus types
-
Opalka D, Matys K, Bojczuk P, Green T, Gesser R, Saah A, et al. Multiplexed serologic assay for nine anogenital human papillomavirus types. Clin Vaccine Immunol 2010;17:818-27.
-
(2010)
Clin Vaccine Immunol
, vol.17
, pp. 818-827
-
-
Opalka, D.1
Matys, K.2
Bojczuk, P.3
Green, T.4
Gesser, R.5
Saah, A.6
-
38
-
-
0032429160
-
A statistically defined endpoint titer determination method for immunoassays
-
Frey A, Di CJ, Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 1998;221:35-41.
-
(1998)
J Immunol Methods
, vol.221
, pp. 35-41
-
-
Frey, A.1
Di Zurakowski, C.J.D.2
-
39
-
-
70350754603
-
HPV 6/11 16, 18 seroprevalence in men in two US cities
-
Dunne EF, Nielson CM, Hagensee ME, Papenfuss MR, Harris RB, Herrel N, et al. HPV 6/11, 16, 18 seroprevalence in men in two US cities. Sex Transm Dis 2009;36:671-4.
-
(2009)
Sex Transm Dis
, vol.36
, pp. 671-674
-
-
Dunne, E.F.1
Nielson, C.M.2
Hagensee, M.E.3
Papenfuss, M.R.4
Harris, R.B.5
Herrel, N.6
-
40
-
-
79955781094
-
Human papillomavirus (HPV) 6 11, 16, and 18 seroprevalence is associated with sexual practice and age: Results from the multinational HPV Infection in Men Study (HIM Study)
-
Lu B, Viscidi RP, Lee JH,WuY, Villa LL, Lazcano-Ponce E, et al.Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study). Cancer Epidemiol Biomarkers Prev 2011;20:990-1002.
-
(2011)
Cancer Epidemiol Biomarkers Prev
, vol.20
, pp. 990-1002
-
-
Lu, B.1
Viscidi, R.P.2
Jhwuy, L.3
Villa, L.L.4
Lazcano-Ponce, E.5
-
41
-
-
79959682925
-
Prevalence of human papillomavirus antibodies in males and females in England
-
Desai S, Chapman R, Jit M, Nichols T, Borrow R, Wilding M, et al. Prevalence of human papillomavirus antibodies in males and females in England. Sex Transm Dis 2011;38:622-9.
-
(2011)
Sex Transm Dis
, vol.38
, pp. 622-629
-
-
Desai, S.1
Chapman, R.2
Jit, M.3
Nichols, T.4
Borrow, R.5
Wilding, M.6
-
42
-
-
78149281564
-
Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: A population-based study in Amsterdam
-
Heiligenberg M, Michael KM, Kramer MA, Pawlita M, Prins M, Coutinho RA, et al. Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: a population-based study in Amsterdam. Sex Transm Dis 2010;37:672-80.
-
(2010)
Sex Transm Dis
, vol.37
, pp. 672-680
-
-
Heiligenberg, M.1
Michael, K.M.2
Kramer, M.A.3
Pawlita, M.4
Prins, M.5
Coutinho, R.A.6
-
43
-
-
84876514633
-
Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection
-
Vriend HJ, Bogaards JA, Van der Klis FRM, Scherpenisse M, Boot HJ, King AJ, et al. Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection. PLoS One 2013;8:e60696.
-
(2013)
PLoS One
, vol.8
-
-
Vriend, H.J.1
Bogaards, J.A.2
Van Der Klis Frm3
Scherpenisse, M.4
Boot, H.J.5
King, A.J.6
-
44
-
-
84865485498
-
Prevalence, incidence, and risk factors for human papillomavirus 16 seropositivity in Australian homosexual men
-
Poynten IM, Jin F, Templeton DJ, Prestage GP, Donovan B, Pawlita M, et al. Prevalence, incidence, and risk factors for human papillomavirus 16 seropositivity in Australian homosexual men. Sex Transm Dis 2012; 39:726-32.
-
(2012)
Sex Transm Dis
, vol.39
, pp. 726-732
-
-
Poynten, I.M.1
Jin, F.2
Templeton, D.J.3
Prestage, G.P.4
Donovan, B.5
Pawlita, M.6
-
45
-
-
0030742296
-
Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men
-
Hagensee ME, Kiviat N, Critchlow CW, Hawes SE, Kuypers J, Holte S, et al. Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men. J Infect Dis 1997;176:625-31.
-
(1997)
J Infect Dis
, vol.176
, pp. 625-631
-
-
Hagensee, M.E.1
Kiviat, N.2
Critchlow, C.W.3
Hawes, S.E.4
Kuypers, J.5
Holte, S.6
-
46
-
-
76149126430
-
Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men
-
Lu B, Hagensee ME, Lee JH, Wu Y, Stockwell HG, Nielson CM, et al. Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men. Cancer Epidemiol Biomarkers Prev 2010;19:511-6.
-
(2010)
Cancer Epidemiol Biomarkers Prev
, vol.19
, pp. 511-516
-
-
Lu, B.1
Hagensee, M.E.2
Lee, J.H.3
Wu, Y.4
Stockwell, H.G.5
Nielson, C.M.6
-
47
-
-
0037111029
-
Seroprevalence of human papillomavirus type 16 infection in the United States
-
Stone KM, Karem KL, Sternberg MR, McQuillan GM, Poon AD, Unger ER, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 2002;186:1396-402.
-
(2002)
J Infect Dis
, vol.186
, pp. 1396-1402
-
-
Stone, K.M.1
Karem, K.L.2
Sternberg, M.R.3
McQuillan, G.M.4
Poon, A.D.5
Unger, E.R.6
-
48
-
-
84866144592
-
Seroprevalence of human papillomavirus (HPV) type 6 and 16 vary by anatomic site of HPV infection in men
-
Lu B, Viscidi RP, Wu Y, Nyitray AG, Villa LL, Lazcano-Ponce E, et al. Seroprevalence of human papillomavirus (HPV) type 6 and 16 vary by anatomic site of HPV infection in men. Cancer Epidemiol Biomarkers Prev 2012;21:1542-6.
-
(2012)
Cancer Epidemiol Biomarkers Prev
, vol.21
, pp. 1542-1546
-
-
Lu, B.1
Viscidi, R.P.2
Wu, Y.3
Nyitray, A.G.4
Villa, L.L.5
Lazcano-Ponce, E.6
-
49
-
-
50549096652
-
Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection
-
Simen-Kapeu A, Kataja V, Yliskoski M, Syrjanen K, Dillner J, Koskela P, et al. Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection. Scand J Infect Dis 2008;40:745-51.
-
(2008)
Scand J Infect Dis
, vol.40
, pp. 745-751
-
-
Simen-Kapeu, A.1
Kataja, V.2
Yliskoski, M.3
Syrjanen, K.4
Dillner, J.5
Koskela, P.6
|